MIRA INFORM REPORT

 

 

Report Date :

15.02.2008

 

IDENTIFICATION DETAILS

 

Name :

P D HINDUJA NATIONAL HOSPITAL AND MEDICAL AND RESEARCH CENTRE

 

 

Registered Office :

Veer Savarkar Marg, Mahim, Mumbai – 400016, Maharashtra

 

 

Country :

India

 

 

Financials (as on) :

31.03.2007

 

 

Date of Incorporation :

1951

 

 

Legal Form :

Hospital and Medical Research Centre

 

 

Line of Business :

Hospital and Medical Research Centre.

 

RATING & COMMENTS

 

MIRA’s Rating :

A

 

RATING

STATUS

PROPOSED CREDIT LINE

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

Fairly Large

 

Status :

Good

 

 

Payment Behaviour :

Regular

 

 

Litigation :

Clear

 

 

Comments :

Subject is a well-established Hospital. We spoke to Mr. Deepak Samant (Director-Finance), Mr. Rajesh Rao (Secretary to the Board of Management) and Mrs. D’souza (Secretary/ Assistant to Director-Admin), but all of them declined to part with any informations. Trade relations are fair. Payments are however reported as usually correct and as per commitments.

 

The organization can be considered normal for business dealings at usual trade terms and conditions.

 

LOCATIONS

 

Registered Office :

Veer Savarkar Marg, Mahim, Mumbai – 400016, Maharashtra, India

Tel. No.:

91-22-24452222/ 24449199/ 24451515/ 24447000

Fax No.:

91-22-24449151

E-Mail :

info@hindujahospital.com

Website :

www.hindujahospital.com

 

 

Corporate Office :

Administrative  Staff College of India, Bella Vista, Raj Bhavan Road, Khairatabad – 500082, India

Tel. No.:

91-40-23310952

E-Mail :

poffice@asci.org.in

 

MANAGEMENT

 

Name :

Mr. S P Hinduja

Designation :

Chairman

 

 

Name :

Mr. G P Hinduja

Designation :

Chairman

 

 

Name :

Mr. P P Hinduja

Designation :

Chairman

 

 

Name :

Mr. A P Hinduja

Designation :

Resident Member

 

 

Name :

Mrs. Usha S. Raheja

Designation :

Resident Member

 

 

Name :

Mrs. Vinod S. Hinduja

Designation :

Resident Member

 

 

Name :

Mr. B S Tolani

Designation :

Resident Member

 

 

Name :

Mr. R. B. Menon

Designation :

Assistant Secretary to the Board

 

 

Name :

Mr. Deepak Tharanee

Designation :

Secretary to the Board of Management

 

 

Name :

Mr. R. J. Shahaney

Designation :

Chairman, Ashok Leyland Limited (Chennai)

 

 

Name :

Mr. J N Amrolia

Designation :

Executive Director, HRD, Ashok Leyland Limited (Chennai)

 

 

Name :

Mr. K Sridharan

Designation :

Executive Director, Finance, Ashok Leyland Limited (Chennai)

 

 

Name :

Mr. S. K. Bapat

Designation :

President, Hinduja Foundation (Mumbai)

 

 

Name :

Mr. Y. M. Kale

Designation :

Group President, Corporate Governance and Development, Hinduja Group, (India)

 

 

Name :

Mr. F. C. Kohli

Designation :

Former Dy. Chairman, Tata Consultancy Services, (Mumbai)

 

 

Name :

Mr. Hemraj Asher

Designation :

Advocate, M/s. Crawford Bayley and Company, (Mumbai)

 

 

Name :

Mr. Raminder Singh

Designation :

President – Media and News, Hinduja Group India, (Mumbai)

 

 

Name :

Mr. Arjun Asrani

Designation :

IFS Retd. (New Delhi)

 

 

Name :

Mr. Anil Harish

Designation :

Tax Expert, M/s. D. M. Harish and Company (Mumbai)

 

 

Name :

Mr. Dr. T. E. Udwadia

Designation :

General Surgeon of P D Hinduja National Hospital (PDHNH)

 

BUSINESS DETAILS

 

Line of Business :

Hospital and Medical Research Centre.

 

GENERAL INFORMATION

 

No. of Employees :

Around 2000

 

 

Bankers :

Induslnd Bank, Mumbai

 

 

 

Banking Relations :

-

 

 

Auditors :

Not Available

 

 

CAPITAL STRUCTURE

 

Capital Investment :

 

Owned :

N.A.

Borrowed :

N.A.

Total :

N.A.

 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

Not Available

 

 

LOCAL AGENCY FURTHER INFORMATION

 

History

 

The situation faced by Bombay in the aftermath of India's partition was grim due to the influx of refugees. Sanitation in the crowded camps was poor.


Health problems had multiplied. It was beyond the ability of city's public hospitals to cope with the situation. Provision of essential health care facility to the ailing poor thus became the need of the hour.


It was at this crucial juncture that a band of Sindhi philanthropists under the leadership of the late Mr. Parmanand Deepchand Hinduja came forward to extend a helping hand.

 

 


Mr. Parmanand Hinduja pooled resources and set-up an outdoor clinic the 'Seth Deepchand Gangaram Hinduja Health Care' in December 1951 in Dubash House, a rented building on Cadell Road (now Veer Savarkar Marg), to cater primarily, to the needs of the refugees.


A few motivated doctors from the Sindhi community formed the core of the medical faculty. It had elementary outpatient facilities and its own dispensary. Just a year later, in February 1953, the 'National Hospital' came into being with 30 beds; the bed strength gradually went upto 70.


To make the hospital's management broad based, it was handed over to the National Health and Education Society' after the Society was formed and registered under the Public Trusts Act.

 


In 1956 the society purchased a plot of land opposite Dubash House and the National Hospital was shifted in 1963 to a new two storeyed building constructed on this plot (now called the East Building) with 100 beds; in addition, expanded outpatient facilities were made available.


It was soon realised that the 100-bed hospital would not be adequate for a major modern health care and Medical Research Centre, which was the ultimate aim. Accordingly, Dubhash House, along with the land on which it stood was purchased in 1967.


Unfortunately, Mr. Parmanand Hinduja passed away in 1971 before concrete steps could be taken to implement his ideas. Thereafter his sons carried forward the legacy of their father, of translating his dream into a reality.


In 1976 the society renamed the National Hospital as the Subject as a humble tribute to the Founder's pioneering efforts to bring modern health care within reach of the common man.

 


The family soon took steps to create a tertiary care hospital. The main goal was to blend technology with human skills and ingenuity by providing state of the art equipment, assembling a team of talented and committed professionals and creating an atmosphere comparable to what exists in foreign countries to dispense quality health care.


The Hinduja brothers entered into a collaborative arrangement with the world-renowned Massachusetts General Hospital in Boston, the oldest and largest of the teaching hospitals associated with the Harvard Medical School for assistance in planning, equipping and staffing the new complex.


Detailed plans were formulated to construct a 16 storeyed building on the newly purchased plot and it was also decided to add two more floors to the east building.


1986 was a landmark in the history of the Hinduja National Hospital. On August 16th, the dream was realized with the commissioning of the new 300-bed tertiary care hospital complex. The project funded by the family, had state of the art equipment and was staffed by a team of brilliant doctors, many of them with foreign qualifications and experience.

 

The concept of full time consultants, which was new to Mumbai, was introduced against odds, while maintaining the pluralistic pattern of hospital-based, visiting and part-time consultants. The principle that all payments to consultants should be through the hospital was also laid down.


In 1991 a new plot of land close to the east building was purchased and two new buildings were constructed to accommodate the nursing school and provide residential quarters for doctors, nurses and nursing students thus making available additional space for medical activities in the east building.

 

 

Website details:

 

Behind the ultra modern and internationally acclaimed in extending world class medical services which are offered at subject lies a 50 years old dream.

 

A mission to assimilate the finest in medical and surgical talent and technique, to bring them closer to the common man. It was nurtured in the heart of their great founder, Mr. Parmanand Deepchand Hinduja – a hard working philanthropist who laid the foundation of the National Hospital, way back in 1951. Today, the Subject stands as a concrete testimony to the fulfillment of his dream.

 

Subject is an ultramodern multi specialty tertiary care hospital with a Medical Research Centre in collaboration with Massachusetts General Hospital (MGH), Boston. The hospital has an inpatient capacity of 351 beds inclusive of 53 critical care beds in different specialties. As a tertiary care hospital, the services offered are comprehensive covering investigation and diagnosis to therapy, surgery and post - operative care. The inpatient services are complemented with a day centre, out-patient facilities and an exclusive centre for health check for executives. Subject was the first multi disciplinary tertiary care hospital to have been awarded the prestigious ISO 9002 Certification from KEMA of Netherlands for Quality Management System. Subject was recently awarded the prestigious ‘Golden Peacock Global Award for Philanthropy in Emerging Economies 2006’

 

 

The Hospitals philosophy is `To provide World Class Quality Health Care Services to all sections of the society' with emphasis on philanthropy. To fulfill this objective the hospital has highly qualified and dedicated medical professionals, paramedics and managerial support staff who regularly enhance their skills to the most contemporary world standards.


The Hospital conducts special training sessions for executives, an ongoing exercise, for enrichment of working knowledge and thus resulting in increasing effectiveness.

 

Subject attaches a lot of importance in Continuing Medical Education programs. Workshops and Seminars are regularly conducted; many of these are attended by doctors from different parts of India and abroad.

 


With over 70 hospital based Consultants; which is a unique feature of the hospital, there is always an experienced specialist available to initiate treatment without delay. The various specialties covered are Cardiology, Cardiothoracic Surgery, Neurology, Neurosurgery, Orthopaedics, Oncology, Ophthalmology, Rheumatology, Endocrinology, ENT, Gastroenterology, Paediatrics, Paediatric Surgery, Paediatric Neurology, Urology, Nephrology, Dermatology, Dentistry, Plastic Surgery, Gynaecology, Pulmonology, Psychiatry, General Medicine and General Surgery.

 


The need for professionally trained hospital managers is being increasingly felt in Indian hospitals, whether private or public, new or old, large or small metropolitan or not. This is largely due to growing recognition that performance levels of hospitals in various managerial and functional areas are falling short of standards that are known to be achievable.

 

Recognizing this need for excellence in hospital administration, the Hinduja Foundation and the Administrative Staff College of India have formed the Hinduja Institute of Healthcare Management (HIHM). This Institute, in collaboration with health management faculty from the Johns Hopkins University, has developed a post-graduate training programme in hospital administration that meets international standards of quality in health management education.

 

 

News Archives:

 

September 2007

 

 

August 2007

 

July 2007

 

June 2007

 

April 2007

 

March 2007

 

February 2007

 

 

January 2007

 

November 2006

 

 

October 2006

 

September 2006

 

August 2006

 

 

April 2006

 

March 2006

 

January 2006

 

December 2005

 

November 2005

 

September 2005

 

August 2005

 

 

 

July 2005

 

March 2005

 

February 2005

 

January 2005

 

December 2004

 

November 2004

 

October 2004

 

September 2004

 

 

August 2004

 

July 2004

 

May 2004

 

March 2004

 

February 2004

 

January 2004

 

October 2003

 

August 2003

 

June 2003

 

April 2003

 

March 2003

 

 

 

Doctors: (List of Doctors with Qualifications)

 

Ambulatory Care

 

Cardiology and Cardiac Angioplasty

 

Cardiothoracic Surgery

 

Critical Care

 

Dermatology

 

Dentistry

 

Endocrinology

 

E.N.T.

 

Gastroenterology

 

General Medicine

 

General Surgery

 

Gastroentrology Surgeon

 

Gynaecology

 

Minimal Access Surgery

 

Nephrology

 

Neurology

 

Neurosurgery

 

Oncology

 

Ophthalmology

 

Orthopaedics

 

 

Paediatrics

 

Paediatric Surgery

 

Psychiatry

 

Plastic Surgery

 

Rheumatology

 

Urology

 

 

Department of Anaesthesiology

 

Department of Lab Medicine

 

Radio Immuno Assay

 

Department of Imaging

 

Nuclear Medicine

 

 

INSPIRATION

Parmanand Deepchand Hinduja (1901-1971)


Paramanand Deepchand Hinduja was the Founder of the Hinduja Group and the Hinduja Foundation. He believed from his early childhood that health and education were the fundamental rights of every person.


This belief led him to establish the National Health and Education Society in 1954. Paramanand Deepchand Hinduja would visit the hospital devotedly every day to meet the patients, enquire after their needs and ensure that they were comfortable and received adequate treatment.

 

He would pay particular attention to the poor and the needy. His method of screening patients to quantify for free treatment was quite simple. He would make the patients declare before the Deities of His Guru and the Almighty that they did not have the means to pay the bills, and provide them with free medical care.


The Hinduja Hospital continues to fulfill his dream of providing world class medical care to all sections of society.



Lalita Girdhar Hinduja (1932-1992)


Smt. Lalita Girdhar Hinduja was the wife of Late Girdhar Hinduja, the eldest son of, Shri Paramand Hinduja.

Widowed at an early age, she was encouraged by her father-in-law to step out of the house and offer her services to the Hospital. Following in his footsteps, Lalita served the Hospital for thirty years.


During her time, the institution grew from strength to strength. She would spend her entire day from morning to evening in the hospital, personally visiting and looking after the patients, inspecting the quality of medical care, administering various aspects of hospital management and constantly devising ways to match the standards of the hospital with those available in the West.


Her affectionate disposition, attention to detail, humane feelings for the staff and simplicity ensured that the Hinduja Hospital operated like a family with a strong sense of belonging, among all medical and non medical personnel. Even today, the staff remembers her with affection and respect.


She remains the torchbearer of the hospital.

 

 

Research Society

‘National Health and Education Society’, subject is approved / recognised by the Department of Science and Technology, Ministry of Science and Technology, Government of India. It is recognised by Mumbai University for the degrees of MSc and PhD by research in January 1993.

 

There is a separate ‘Research Laboratory’ which is accredidated by CAP [College of American Pathologists]. It has facilities and equipment necessary for basic research – especially in molecular biology. There are 16 MSc/PhD seats. Students do high quality research for their University degree.

 

So far 49 students have registered for MSc and PhD of Mumbai University. Of these 15 have obtained MSc degree, 8 have obtained PhD. 3 have submitted synopsis/thesis. Over the years a total of 382 research projects have been sanctioned and significant contributions made.



Research activities are summarised below

 

 


On-Going Research Projects

 

Sr. No.

Project Code

Type of Research

Status

Project Title

Chief Investigator

Date of Approval

Year of starting

 

 

 

 

 

 

 

 

1

245-02-ZFU

Clinical Research

Ongoing

Prevalence of sleep disordered breathing in patients with heart failure and effect of 3 months of C-PAP in these patients

Dr Z F Udwadia

May-02

2005

2

265-03-SS

Lab Studies

Ongoing

Evaluation of a novel tested PCR technique in the diagnosis of abdominal TB from tissue biopsy and blood  /  Molecular biology techniques in the diagnosis of abdominaltuberculosis??

Dr Sudeep Shah

Jun-03

2003

3

271-03-BKM/TFA

Basic Research

Ongoing

Methylation status of the RB1 gene CpG island in human Pituitary Tumors

Dr B K Mishra

Feb-05

2005

4

272-03-TFA

Basic Research

Ongoing

The Genetic Basis of Atherothrombotic coronary artery disease in the Indian population

Dr T F Ashavaid

Sep-03

2003

5

273-03-TFA

Lab Studies

Ongoing

Development of a Multilocus assay for candidate markers in Indian patients with Cardiovascular disease risk

Dr T F Ashavaid

Sep-03

2003

6

280-04-PA

Lab Studies

Ongoing

Hepatitis B virus genotyping and its relevance to severity of liver diseases and treatment.

Dr P Abraham

Jun-04

2004

7

283-04-BVS

Basic Research

Ongoing

Study of gene polymorphisms related to drug levels and clinical behaviour in kidney transplant patients: Indian scenario

Dr B V Shah/ Dr T F Ashavaid

Sep-04

2004

8

287-04-AD

Lab studies

Ongoing

To establish a full range of compatibility test in our transfusion set up

Dr Anand Deshpande

Jul-04

2005

9

292-04-VA

Lab studies

Ongoing

To study behaviour of mycobacterium tuberculosis in new & relapsed cases of osteoarticular tuberculosis

Dr Vikas Agashe

Aug-04

2004

10

294-04-VRJ

Lab studies

Ongoing

Comparison of two techniques ie ELISA and Western blotting for the detection of Antigens causing ANCA positivity

Dr V R Joshi

Aug-04

2004

11

296-04-RW

Clinical research

Ongoing

Incidence of Deep Venous Thrombosis in patients (DVT) in hospitalised patients with acute exacerbation of COPD- a pilot study

Dr R Wadhwani

Jan-05

2005

12

299-04-TFA

Basic research

Ongoing

LDL and HDL subfractions, their genetic basis and the role of 5-Lipoxygenase activator protein (FLAP) promoter polymorphism in Coronary Heart disease

Dr T F Ashavaid

Dec-04

2004

13

300-04-VP

Lab studies

Ongoing

Study of Vitamin D receptor Gene polymorphism and autoimmune markers of Pancreatic Beta cell destruction in Type I diabetes

Dr Vipla Puri

Sep-04

2004

14

301-04-AM

Lab studies

Ongoing

Development of a Reverse Line Blot Hybridization (RLBH) assay for species identification of mycobacteria and drug resistance testing in M.tuberculosis complex

Dr Ajita Mehta

Dec-04

2005

15

302-04-TFA

Lab studies

Ongoing

Standardization of TPMT and DPD gene variations for diagnostic use for patients treated with thiopurines and 5-Fluorouracil.

Dr T F Ashavaid

Feb-05

2005

16

307-05-ABG

Clinical research

Ongoing

Determination of BMD in Healthy Indian Women

Dr Ashwini Bhalerao-Gandhi

Feb-05

2005

17

312-05-JK

Clinical research

ongoing

Prospective study of renal disease in primary Sjogren's syndrome (SS)

Dr Jatin Kothari

Jan-05

2005

18

316-05-CR

Lab studies

Ongoing

Evaluation of excretory secretory antigenic Target-6 (ESAT 6) / CFP 10 and phenolic glycolipid (PGL 1) antigens in the serological diagnosis of tuberculosis - a multicentric trial

Dr Camilla Rodriques

Apr-05

2005

19.

317-05-VPU

Drug Trial

Ongoing

A Randomized double-blind, Placebo-Controlled, Fixed dose ranging study to Assess the Safety, Tolerability, and Efficacy of Topiramate Oral Liquid and sprinkle formulations as an Adjunct to concurrent anticonvulsant therapy for Infants (1 to 23 months of age, inclusive) with refractory partial onset seizures, with open-label extension

Dr Vrajesh Udani

Dec-05

2005

20

319-05-RAS

Lab studies

Ongoing

Is Serum Cystatin C a better marker of Glomerular filtration rate than Creatinine clearance and DTPA renal clearance? - A preliminary study

Dr R A Sirsat

Aug-05

2005

21.

320-05-MC

Drug Trial

Ongoing

H-7U-MC-IDAS A pivotal open-label parallel study to evaluate the safety and efficacy of human Insulin inhalation powder (HIIP) compared to jnjectable insulin in patients with Diabetes and COPD/Asthma

Dr Manoj Chaddha

Oct-05

2005

22.

323-05-MC

Drug Trial

Ongoing

Study of pitavastatin 4 mg v/s atorvastatin 20 mg (following up-titration) in patients with Type II Diabetes Mellitus and combined dyslipidemia Protocol NK-104-305

Dr Manoj Chaddha

Aug-05

2005

23.

324-05-RAS

Clinical research

Ongoing

Data Analysis of renal transplant registry at a single transplant centre/Analysis of renal transplant data registry at PDHNH & MRC

Dr R A Sirsat

Aug-05

2005

24.

325-05-RAS

Therapeutic

Ongoing

Is pamidronate more effective than alendronate in the prevention of steroid induced osteoporosis in kidney transplant patients?

Dr R A Sirsat

Aug-05

2005

25.

328-05-VD

Basic research

Ongoing

Genomic analysis of RET protooncogen in Familial Medullary Thyroid Carcinoma (FMTC)

Dr V Deshmane

Oct-05

2005

26.

329-05-SA

Drug Trial

Ongoing

Protocol No : EPO-ANE-3010/Amendment INT-1: A Randomized Open Label, Multicenter, Phase 3 study of Epoetin Alfa plus Standard Supportive Care v/s Standard Supportive Care in Anemic patients with metastatic breast cancer receiving first line standard chemotherapy

Dr S Almel

Apr-06

2006

27.

330-05-MC

Drug Trial

Ongoing

Safety and efficacy of 'Osteoform' (rh parathyroid hormone (1-34) in increasing Bone mineral density in osteoporosis

Dr Manoj Chaddha

Feb-06

2006

28.

331-05-DD

Clinical research

Ongoing

Establishing screening for Hereditary non polyphosis colorectal cancer (HNPCC)

Dr Devendra Desai

Nov-05

2005

29.

332-05-MRL

Drug Trial

Ongoing

To compare the efficacy and safety of Carbonyl Iron to Ferrous Fumarate in pediatric patients with Iron deficiency anemia (IDA) 

Dr M R Lokeshwar

Feb-06

2006

30.

333-05-NS

Drug Trial

Ongoing

To compare the efficacy and safety of Carbonyl Iron in pediatric patients with Iron deficiency anemia (IDA) 

Dr Nitin Shah

Feb-06

2006

31.

334-05-AA

Drug Trial

Ongoing

Therapeutic confirmatory study to evaluate the safety and efficacy of AropotinTM (recombinant human erythropoetin) in CRF (Chronic Renal Failure) patients

Dr A Almeida

Feb-06

2006

32.

335-06-ZFU

Drug Trial

Ongoing

A Double Blind, Placebo Controlled, Parallel, Multi-Center Study on extended VTE Prophylaxis in Acute III Medical Patients with Prolonged Immobilization

Dr Z F Udwadia

Mar-06

2006

33.

337-06-AP

Lab studies

Ongoing

Do the levels of pro and anti-inflammatory cytokines in the induced sputum of children with asthma, co-relate with the severity classification of asthma?

Dr Asha Pherwani

May-06

2006

34

338-06-FNK

Drug Trial

Ongoing

Nice Registry - NovoSeven (rFVIIa) in critical care

Dr F N Kapadia

May-06

2006

35.

340-06-ST

Drug Trial

Ongoing

Clinical evaluation studies of 32p_SMPC (Samarium phosphate colloid) injection for Radiation synovectomy

Dr S Tikoo

May-06

2006

36.

343-06-AJ

Drug Trial

Ongoing

To evaluate efficacy and safety of TAK-390 MR (30 mg QD x 60 mg QD) and an Active comparator, Lansoprazole (30 mg QD) on Healing of Erosive esophagitis.

Dr Anand Joshi

May-06

2006

37.

342-06-MC

Drug Trial

Ongoing

A randomized, double-blind study comparing the efficacy and safety of a fixed combination of Fenofibrate and Metformin vs Metformin alone in patients with Type 2 DM and Dyslipidemia not appropriately controlled with a statin.

Dr Manoj Chaddha

May-06

2006

38.

341-06-SDMC

Drug Trial

Ongoing

Gastric stimulation using the TANTALUS tm system in the treatment of overweight and obese Type 2 Diabetic subjects

Dr Shrihari Dhorepatil

May-06

2006

39.

344-06-CR/AM

Lab studies

Ongoing

Evaluation of p-nitrobenzoic acid (PNBA) assay against NAP and Accuprobe for species identification of mycobacteria.

Dr Camilla Rodriques

Jul-06

2006

40.

346-06-RS

Clinical research

Ongoing

Prospective study of Outcome of a Cohort of Patients with Systemic Lupus Erythemaosus

Dr Rohini Samant

Jul-06

2006

 

 

Home

The School of Nursing at Subject was established in 1981 by the great visionary and pioneer Mrs. Lalita Girdhar Hinduja (1932-1992), who believed in providing world class nursing care to all.


The goal of the Lalita Girdhar Hinduja College of Nursing is to set national standards for excellence in the education of nurses, lead the development and application of clinically relevant science, and create service strategies for meeting the health needs of a diverse society. This goal is supported by the dynamic, multidisciplinary institutional philosophy of subject to provide “Quality Care for All” through a unified approach towards education, research and clinical practice.


The Lalita Girdhar Hinduja College of Nursing has a rich heritage of over 25 years with more than 439 graduates in India and abroad. From the academic year 2007 onwards the College of Nursing is offering a 4 year B.Sc nursing programme with 30 students annually.

 


Landmarks in The Lalita Girdhar Hinduja College of Nursing

 

 

 

AT A GLANCE

 

Ms. Usha Raheja:          Patron

Ms. Vinoo Hinduja:        Member Board of Management and Secretary General

Mr. Pramod Lele:          Chief Executive

Mr. Deepak Tharanee:  Secretary to Board of Management

Ms. Jaya Kuruvilla:        Principal

University   :                  Maharsahtra University of Health Sciences

Council:                         Central - Indian Nursing Council State - Maharashtra Nursing Council

Area                              College of Nursing

Email address               nursingedu@hindujahospital.com

Website                        http://www.hindujahospital.com

Telephone Nos:            Direct : 022 28269172  022 28269159,60( Board ) 403 Extn Fax No : 022 28269168

Address                        Emerald Court, D wing Kondivita Lane, Marol Pipe Line Andheri (East), Mumbai –400 059

 

 

CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                  None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                          None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                          None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 

 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency
Unit

Indian Rupees

US Dollar

1

Rs.39.65

UK Pound

1

Rs.77.84

Euro

1

Rs.57.78

 

 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

7

PAID-UP CAPITAL

1~10

7

OPERATING SCALE

1~10

7

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

8

--PROFITABILIRY

1~10

6

--LIQUIDITY

1~10

7

--LEVERAGE

1~10

7

--RESERVES

1~10

7

--CREDIT LINES

1~10

7

--MARGINS

-5~5

-

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

NO

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

TOTAL

 

63

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Unfavourable & favourable factors carry similar weight in credit consideration. Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

NR

In view of the lack of information, we have no basis upon which to recommend credit dealings

No Rating

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions